CPTx welcomed Matt Kane as CFO to the executive team.
Public source
Publisher name
Public post
๐๐ฃ๐ง๐ ๐ฎ๐ฝ๐ฝ๐ผ๐ถ๐ป๐๐ ๐ ๐ฎ๐๐ ๐๐ฎ๐ป๐ฒ ๐ฎ๐ ๐๐ต๐ถ๐ฒ๐ณ ๐๐ถ๐ป๐ฎ๐ป๐ฐ๐ถ๐ฎ๐น ๐ข๐ณ๐ณ๐ถ๐ฐ๐ฒ๐ฟ! We are excited to welcome Matt Kane as CFO to our executive team. As a pioโฆ
Company
CPTx
Pioneering the development of in vivo genetic medicines built with immune-quiet DNA.
- Industry
- Biotechnology Research
- Location
- Planegg, DE
- Company size
- 11โ50 employees
About CPTx
CPTx is a leader in developing the next generation of non-viral, DNA-based in vivo CAR T cell therapies, uniquelyย overcoming key challenges in both oncology and autoimmune disease. CPTxโs immune-quiet proprietary DNA platform enables control over the duration of gene expression from transient to permanent, supports the co-delivery of multiple genes, and allows for repeat administration.
See moreDiscover more
Similar signals
Similar public activity from other companies.
People
Typewriter Therapeutics, Inc.
Typewriter Therapeutics, Inc. appointed Matthew Stanton, PhD as Chief Executive Officer and Leanne Peiser, DPhil as Chief Scientific Officer.
People
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. welcomed Kristie Lee as Clinical Research Associate to support ongoing clinical trials through data management, compliance oversight, and vendor coordination.
People
Editas Medicine
Editas Medicine welcomed Dan Ory, M.D., as Chief Medical Officer.
People
Slate Medicines
Slate Medicines welcomed Whitney Page as its new Vice President of Corporate Development.
People
Mediar Therapeutics